Oxford University/ AstraZeneca COVID-19 vaccine approved

Oxford University/ AstraZeneca COVID-19 vaccine approved

December 31, 2020

The COVID-19 vaccine developed by Oxford University/AstraZeneca was yesterday given regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting required safety, quality and effectiveness standards.

Like many community pharmacists, PSNC is keen to see the sector able to play a greater role in the vaccination programme now the Oxford University/AZ vaccine can be used; we have clearly communicated that message to the Department of Health and Social Care and NHS England and NHS Improvement and will continue to do so.

In the meantime, PSNC is working with the other pharmacy bodies on generating press coverage, making clear that we believe the skills of community pharmacists and their teams should be used by the NHS to help deliver this mass vaccination programme.

Alastair Buxton, PSNC Director of NHS Services, said:

“The approval of a second vaccine, and one that has less complex handling characteristics when compared to the Pfizer/BioNTech vaccine, is a positive step. The rollout of the vaccination programme will not be without its challenges, but community pharmacists and their teams are used to overcoming hurdles to provide the best care to their patients, so we believe their skills should be used by the NHS to help administer the tens of millions of vaccinations that will be needed to help England escape from the grip of the pandemic.”



Posted in: , , ,


More Latest News >

PSNC launches GP CPCS animation

PSNC has launched a video animation and infographic explaining how GP practices can refer into the NHS Community Pharmacist Consultation...